Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
479.60
+5.25 (1.11%)
At close: Mar 9, 2026
NSE:AKUMS Market Cap
NSE:AKUMS has a market cap or net worth of 73.43 billion as of March 9, 2026. Its market cap has decreased by -10.87% in one year.
Market Cap
73.43B
Enterprise Value
57.98B
Revenue
42.60B
Ranking
n/a
PE Ratio
23.08
Stock Price
479.60
Market Cap Chart
Since August 6, 2024, NSE:AKUMS's market cap has decreased from 125.32B to 73.43B, a decrease of -41.41%. That is a compound annual growth rate of -28.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 73.43B | 5.78% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 79.72B |
| Aarti Pharmalabs | 63.47B |
| Cohance Lifesciences | 107.08B |
| Alivus Life Sciences | 112.31B |
| Sun Pharma Advanced Research Company | 40.23B |
| Innova Captab | 38.91B |
| Alembic Pharmaceuticals | 139.26B |
| RPG Life Sciences | 30.97B |